Cronos Ownership
| CRON Stock | USD 2.05 0.04 1.99% |
Shares in Circulation | First Issued 2013-06-30 | Previous Quarter 382.2 M | Current Value 386 M | Avarage Shares Outstanding 238.7 M | Quarterly Volatility 151.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cronos |
Cronos Stock Ownership Analysis
About 46.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cronos Group recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. Cronos operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 626 people. For more info on Cronos Group please contact Michael JD at 416 504 0004 or go to https://www.thecronosgroup.com.Besides selling stocks to institutional investors, Cronos also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cronos' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cronos' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Cronos Quarterly Liabilities And Stockholders Equity |
|
Cronos Insider Trades History
About 46.0% of Cronos Group are currently held by insiders. Unlike Cronos' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cronos' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cronos' insider trades
Cronos Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cronos is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cronos Group backward and forwards among themselves. Cronos' institutional investor refers to the entity that pools money to purchase Cronos' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 550.2 K | Penserra Capital Management, Llc | 2024-06-30 | 544.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 535.6 K | Kerrisdale Advisers, Llc | 2024-06-30 | 458.2 K | Qube Research & Technologies | 2024-06-30 | 432.2 K | Swiss National Bank | 2024-09-30 | 415.4 K | Intact Investment Management, Inc. | 2024-09-30 | 377.9 K | Charles Schwab Investment Management Inc | 2024-09-30 | 374.6 K | Goldman Sachs Group Inc | 2024-06-30 | 367.4 K | Chescapmanager Llc | 2024-06-30 | 8 M | Vanguard Group Inc | 2024-09-30 | 7.5 M |
Cronos Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cronos insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cronos' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cronos insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cronos Outstanding Bonds
Cronos issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cronos Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cronos bonds can be classified according to their maturity, which is the date when Cronos Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Cronos Corporate Filings
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 30th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of July 2024 An amendment to a previously filed Form 8-K | ViewVerify |
| 5th of July 2024 Other Reports | ViewVerify |
Pair Trading with Cronos
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.Moving together with Cronos Stock
| 0.64 | VALN | Valneva SE ADR Downward Rally | PairCorr |
Moving against Cronos Stock
| 0.58 | GILD | Gilead Sciences | PairCorr |
| 0.57 | BMY | Bristol Myers Squibb | PairCorr |
| 0.43 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.31 | VRDN | Viridian Therapeutics | PairCorr |
The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Earnings Share (0.12) | Revenue Per Share 0.267 | Quarterly Revenue Growth 0.46 | Return On Assets (0.04) |
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.